Market Access & Pricing in the EU

Aims and objectives:

Market access for drugs and medical devices is complex and requires careful preparation for launch. Knowledge of the underlying health systems and the different, mutually influencing pricing systems in the EU-5 countries is essential for it.

In our series of online seminars you will receive the most important information for successful market access in the EU5 countries.

You can book the topics together or individually, depending on your interests:

- 25th of March: Market Access and Pricing in France & Italy

- 29th of April: Market Access and Pricing in Germany and the UK

- 27th of May: Market Access in Spain & Scandinavia

- 10th of June: EU-trends in Market Access & Pricing

Topics:

- Reference Pricing in Europe

- Payer-Archetyping

- Market Access and Pricing in France, Italy, Spain, UK, Scandinavia and Denmark

- Specialties with regard to ATMPs/Gentherapeutics

- HTA process and the role of RWE in the HTA context

- Cross country tenders - upcoming trends

Who should attend?

This series of online seminars is aimed at specialists and executives in the healthcare industry who are involved in market access and pricing in Europe.